NCT02333773View on ClinicalTrials.gov

Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2020

Study Completion Date

January 1, 2021

Conditions
Liver Cancer
Interventions
PROCEDURE

Irreversible electroporation (IRE)

Irreversible Electroportion For Unresectable Portal venous tumor emboli guide with ultrasound or/and CT.

Trial Locations (1)

510665

Fuda Cancer Hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02333773 - Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli | Biotech Hunter | Biotech Hunter